← Every company
Halozyme Therapeutics Inc SEC Filings
What Halozyme Therapeutics Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
HALO overview →Filings on file
143
since Nov 7, 2016
Warning signs
2
latest Nov 12, 2019
Last results
Aug 6, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Aug 18, 2026 | Executive or director change 8-K | Read ↗ |
| Jul 2, 2026 | Executive or director change 8-K | Read ↗ |
| Apr 30, 2026 | Executive or director change 8-K | Read ↗ |
| Mar 12, 2026 | Executive or director change 8-K | Read ↗ |
| Dec 9, 2025 | Executive or director change 8-K | Read ↗ |
| Dec 8, 2025 | Executive or director change 8-K | Read ↗ |
| Nov 24, 2025 | Executive or director change 8-K | Read ↗ |
| Nov 3, 2025 | Executive or director changeResults announced 8-K | Read ↗ |
| Oct 6, 2025 | Executive or director change 8-K | Read ↗ |
| Mar 21, 2025 | Executive or director change 8-K | Read ↗ |
| Feb 13, 2025 | Executive or director change 8-K | Read ↗ |
| Feb 23, 2023 | Executive or director change 8-K | Read ↗ |
| Feb 6, 2023 | Executive or director change 8-K | Read ↗ |
| Mar 15, 2022 | Executive or director change 8-K | Read ↗ |
| Feb 3, 2022 | Executive or director change 8-K | Read ↗ |
| Dec 13, 2021 | Executive or director change 8-K | Read ↗ |
| May 5, 2021 | Executive or director change 8-K | Read ↗ |
| May 3, 2021 | Executive or director change 8-K | Read ↗ |
| Feb 24, 2020 | Executive or director change 8-K | Read ↗ |
| Nov 5, 2019 | Material impairmentExecutive or director changeRestructuring 8-K | Read ↗ |
| Dec 13, 2018 | Executive or director change 8-K | Read ↗ |
| Sep 10, 2018 | Executive or director change 8-K | Read ↗ |
| Apr 6, 2018 | Executive or director change 8-K | Read ↗ |
| Mar 22, 2018 | Executive or director change 8-K | Read ↗ |
| Sep 29, 2017 | Executive or director change 8-K | Read ↗ |
| May 9, 2017 | Executive or director change 8-K | Read ↗ |
Source: Halozyme Therapeutics Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on HALO
Company overviewEverything on HALO in one place, with the price.Insider tradingWhat HALO's own officers and directors buy and sell.Planned salesSales HALO insiders have filed notice of.Who owns itEvery manager reporting a position in HALO.Funds holding itWhich funds and ETFs hold HALO, and how big a bet.LobbyingWhat HALO spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on HALO's account, and who they worked for.PatentsWhat HALO is filing at the patent office.